β-Nicotinamide-Adenine Dinucleotide Phosphate, Reduced (β-NADPH)

β-Nicotinamide-Adenine Dinucleotide Phosphate, Reduced (β-NADPH) is a coenzyme useful for creatine, ammonia and urea reagents and the assessment of cytochrome P450 reductase activity. This NADPH is made by our parent Oriental Yeast Co., LTD in Japan, and inventories are available at our warehouse in California.

Download Datasheets

Catalog Number Pack Size

Catalog Number 44330000

Pack Size 100 mg

Catalog Number 44332000

Pack Size 1 g

Catalog Number 44332900

Pack Size 10 g, 50 g, 250 g, 1000 g

Specifications

Source

Yeast

CAS

2646-71-16

Formula

C₂₁H₂₆N₇O₁₇P₃Na₄

Formula / molecular Weight

833.35

Product Form

Lyophilized powder

Purity

> 95%

UV Spectral Analysis

Ratios at pH 10.0A₃₄₀/A₂₆₀ (0.43 ± 0.02)ε at 260nm(14.4 ± 0.5) x 103ε at 340nm (6.2 ± 0.2) x 103

Applications

Our β-Nicotinamide-Adenine Dinucleotide Phosphate, Reduced (β-NADPH) is applicable for making Ammonia, Urinary Urea-Nitrogen (UUN), and Cholinesterase (ChE) reagents. It is also suitable for Cytochrome P450 Research and Biocatalysis.

Additional products associated with these reagents include Glutamate Dehydrogenase (GLDH), and recombinant Urease (rUrease).

Storage Condition

Short Term: ~ 5°C Long Term: Below -20°C

Related Products

β-Nicotinamide-Adenine Dinucleotide Phosphate, Monopotassium salt (β-NADP-K)

β-Nicotinamide-Adenine Dinucleotide Phosphate, Monosodium salt (β-NADP-Na)

β-Nicotinamide-Adenine Dinucleotide, Reduced (β-NADH)

Glutamate Dehydrogenase (NADP), recombinant from bacteria (rGlDH)

β-Nicotinamide-Adenine Dinucleotide Phosphate, Oxidized, Disodium salt (β-NADP-2Na)

β-Nicotinamide-Adenine Dinucleotide, Oxidized (β-NAD)

Product Citations

Peters, C. & Buller, R. (2019). Linear enzyme cascade for the production of (–)-iso-isopulegol. Zeitschrift für Naturforschung C, 74(3-4), 63-70. https://doi.org/10.1515/znc-2018-0146

Kowalski, J. P., McDonald, M. G., Whittington, D., Guttman, M., Scian, M., Girhard, M., Hanenberg, H., Wiek, C., & Rettie, A. E. (2019). Structure-Activity Relationships for CYP4B1 Bioactivation of 4-Ipomeanol Congeners: Direct Correlation between Cytotoxicity and Trapped Reactive Intermediates. Chemical research in toxicology, 32(12), 2488–2498. https://doi.org/10.1021/acs.chemrestox.9b00330

Nichols, J. W., Fitzsimmons, P. N., Hoffman, A. D., & Wong, K. In vitro‐in vivo extrapolation of hepatic biotransformation data for fish. III. An in‐depth case study with pyrene. Environmental Toxicology and Chemistry.

Fujino, C., Kuzu, T., Kubo, Y., Hayashi, K., Ueshima, S., & Katsura, T. (2023). Attenuation of phenobarbital‐induced cytochrome P450 expression in carbon tetrachloride‐induced hepatitis in mice models. Biopharmaceutics & Drug Disposition.

Paudel, S., Jo, H., Lee, T., & Lee, S. (2023). Selective inhibitory effects of suberosin on CYP1A2 in human liver microsomes. Biopharmaceutics & Drug Disposition.

© Copyright 2024. All Rights Reserved.

Privacy | Sitemap